This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ronald E. Carr, M.D.
Department of Ophthalmology New York University Medical Center 550 First Ave. New York 16

Arch Ophthalmol. 1962;68(5):718.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor:

—In order to prevent confusion in future literature it is desirable to correct the terminology as appeared in the article: "Ocular Manifestations of Ethambutol," ARCH. OPHTHAL. 67:566-571, 1962. At the time this drug was studied in this individual the dl isomer of 2,2'-(ethylenediamino)-di-l-butanol had been tentatively assigned the generic name ethambutol. When it became known that the active component, so far as antituberculous activity is concerned, is the dextroisomer, the generic name was officially assigned to only the dextroisomer. Whether the toxicity that occurred with the racemic mixture will be the same with the dextroisomer, now known as ethambutol, remains to be elucidated.

The Correspondence Section welcomes inquiries and comments of a general or specific nature. The Editors may try to answer some of the questions, but more valuable will be answers volunteered by others who have had especial experience related to the questions posed. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?